Gastroenterology
Volume 138, Issue 3 , Pages 1155-1165.e2 , March 2010

Induction of p53 Renders ATM-Deficient Mice Refractory to Hepatocarcinogenesis

  • Narci Teoh

      Affiliations

    • Australian National University Medical School at The Canberra Hospital, Canberra, Australia
    • ,
  • Pawan Pyakurel

      Affiliations

    • Australian National University Medical School at The Canberra Hospital, Canberra, Australia
    • ,
  • Yock Young Dan

      Affiliations

    • National University Hospital, National University of Singapore, Singapore
    • ,
  • Karen Swisshelm

      Affiliations

    • Department of Pathology, University of Colorado, Denver, Colorado
    • ,
  • Jing Hou

      Affiliations

    • Australian National University Medical School at The Canberra Hospital, Canberra, Australia
    • ,
  • Claudia Mitchell

      Affiliations

    • Department of Pathology, University of Washington, Seattle, Washington
    • ,
  • Nelson Fausto

      Affiliations

    • Department of Pathology, University of Washington, Seattle, Washington
    • ,
  • Yansong Gu

      Affiliations

    • Department of Radiation Oncology and Immunology, University of Washington, Seattle, Washington
    • ,
  • Geoffrey Farrell

      Affiliations

    • Australian National University Medical School at The Canberra Hospital, Canberra, Australia
    • Corresponding Author InformationReprint requests Address requests for reprints to: Geoffrey C. Farrell, MD, FRACP, Professor of Hepatic Medicine and Director of Hepatology, Australian National University Medical School at The Canberra Hospital, Level 2, Building 1, Yamba Drive, Garran, ACT 2605, Australia. fax: (61) 2 62815179

Received 12 September 2008 ,Accepted 10 November 2009.

References 

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576
  2. Bruix J, Boix J, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell. 2004;215–219
  3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687
  4. Aihara T, Noguchi S, Sasaki Y, et al. Clonal analysis of precancerous lesions of hepatocellular carcinoma. Gastroenterology. 1996;111:455–461
  5. De Souza AT, Hankins GR, Washington MK, et al. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet. 1995;11:447–449
  6. Khanna KK, Jackson SP. DNA double-strand breaks: signalling, repair and the cancer connection. Nat Genet. 2001;27:247–254
  7. Van Gent DC, Hoeijmakers JHJ, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet. 2001;2:196–206
  8. Teoh N, Dan YY, Swisshelm K, et al. Defective Ku70 DNA double strand break repair enhances hepatocarcinogenesis in mice. Hepatology. 2008;47:2078–2088
  9. Loyer P, Glaise D, Cariou S, et al. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem. 1994;269:2491–2500
  10. Buitrago-Molina LE, Pothiraju D, Lamle J, et al. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage. Hepatology. 2009;50:500
  11. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2:594–604
  12. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3:155–168
  13. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001;21:4129–4139
  14. Cortez D, Guntuku S, Qin J, et al. ATR and ATRiP: partners in checkpoint signalling. Science. 2001;294:1713–1716
  15. Edwards R, Bentley NJ, Carr AM. A Rad3-Rad26 complex responds to DNA damage independently of other checkpoint proteins. Nat Cell Biol. 1999;1:393–398
  16. Cortez D, Wang Y, Qin J, et al. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double strand breaks. Science. 1999;286:1162–1166
  17. Lee JS, Thorgeirsson SS. Genome scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction and identification of therapeutic targets. Gastroenterology. 2004;127:S51–S55
  18. Westphal CH, Rowan S, Schmaltz C, et al. atm and p53 Cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet. 1997;16:397–401
  19. Xue W, Zender L, Miething C, et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007;445:656–660
  20. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 leads to tumor regression in vivo. Nature. 2007;445:661–665
  21. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999;21:111–114
  22. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology. 2004;40:276–283
  23. Wong K-K, Maser R, Bachoo RM, et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 2003;421:643–647

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Australian NHMRC project grant No. 418100, NHMRC program grant No. 358398, NIH grant CA No. 74131, and ACS grant No. RSG-04-019-01-CNE.

PII: S0016-5085(09)01998-2

doi: 10.1053/j.gastro.2009.11.008

Gastroenterology
Volume 138, Issue 3 , Pages 1155-1165.e2 , March 2010

Article Tools

* Image Usage & Resolution